PRAME

preferentially expressed antigen in melanoma

PRAME; preferentially expressed antigen in melanoma; MAPE; melanoma antigen preferentially expressed in tumors; cancer/testis antigen 130; CT130; 4930534P07Rik; OIP 4; OIP-4; OIP4; OPA interacting protein 4; Opa interacting protein OIP4; OPA-interacting protein 4; PRAME_HUMAN; Preferentially expressed antigen of melanoma; RP23-250F8.3; Opa-interacting protein OIP4;

PRAMEF10

PRAME family member 10

PRAMEF10; PRAME family member 10; MGC138413; MGC138415; RP5-845O24.7;

PRAMEF12

PRAME family member 12

PRAMEF12; PRAME family member 12; OTTHUMG00000001927;

PRAMEF3

PRAME family member 3

PRAMEF3; PRAME family member 3; RP11-248D7.1;

PRAMEF9

PRAME family member 9

PRAMEF9; PRAME family member 9; PRAME family member 9/15; PRAM9_HUMAN; PRAMEF15;

PRAMEF14

PRAME family member 14

PRAMEF15

PRAME family member 15

PRAMEF16

PRAME family member 16

PRAMEF17

XPRAME family member 17

Gm13107; OTTMUSG00000010438;

PRAMEF18

PRAME family member 18

PRAMEF19

PRAME family member 19

PRAMEF2

PRAME family member 2

DJ845O24.3; RP5-845O24.1;

PRAMEF22

PRAME family member 22

PRAMEF3L;

PRAMEF4

PRAME family member 4

RP5-845O24.6;

PRAMEF6

PRAME family member 6

Gm13099; OTTMUSG00000010429;

PRAMEF7

PRAME family member 7

PRAMEF8

PRAME family member 8

AU023234; 4732496O08Rik;

PRAMEF11

PRAME family member 11

PRAMEF13

PRAME family member 13

PRAMEF21

PRAME family member 21

PRAMEF5

PRAME family member 5